Published:
Category: Group updates
CCTG Recognition Awards Nominations are Open

The Canadian Cancer Trials Group is seeking nominations for the 2022 Recognition Awards honouring individuals who have contributed significantly to the mission and activities of the Group.

Read More



Published:
Category: Group updates

The Canadian Cancer Trials Group is actively seeking CRA representatives from Canadian Member sites to sit on Disease Site Committee Executives as well as the CCTG CRA Executive Committee.

Read More

Published:
Category: News

With funding provided through the Precision Oncology Patient Innovation Award from Bayer, the Canadian Cancer Clinical Trials Network (3CTN) will create the Precision Oncology Map, a uniquely comprehensive, visual representation of all cancer clinical trials active in Canada that have a focus on precision medicine. The goal is to go beyond existing trial registry data to make it easier for cancer patients, their caregivers and the research community to locate suitable clinical trials, particularly precision medicine trials involving specific biomarkers and targeted therapies.

Read More

Published:
Category: News

Cancer is not a single disease; it is hundreds. Cancers of the lung, breast, prostate, and colon are the most common forms of the disease, and account for about half of all diagnoses. But less common forms of cancer also account for about half of diagnoses, and these are not as well studied. Some of them are extremely rare, with only a few people diagnosed each year.

Read More

Published:
Category: Publications
Publications: EN7, MA17R, PR17, MA37, CEC2
Recent CCTG publications EN7, MA17R, PR17, MA37, CEC2 Read More

Published:
Category: Trials
CCTG CLC3 (SWOG S1925) study: Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL has been centrally activated.
Read More

Published:
Category: Trials
IND234 substudy A: A Phase II Study of Adavosertib and IND223: A Phase II Study of Palbociclib Read More



Published:
Category: Group updates

CCTG Central Office Holiday coverage

For 2021/2022 holiday season CCTG will operate with limited coverage on the following dates:

Read More